FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Taro Pharmaceuticals U.S.A., Inc.)

View source ↗

Summary

FDA approves a supplemental application for enalapril maleate by Taro Pharmaceuticals U.S.A., Inc., pertaining to an approved product (generic enalapril).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Heart Failure
• Hypertension
• Left Ventricular Dysfunction
• Myocardial Infarction

Drugs mentioned

• Enalapril maleate (enalapril maleate)

Snippet

SUPPL AP for ENALAPRIL MALEATE (ENALAPRIL MALEATE)